- Home
- HOTH vs MGRX Comparison
HOTH vs MGRX Comparison
Compare HOTH & MGRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOTH
- MGRX
- Stock Information
- Founded
- HOTH 2017
- MGRX 2021
- Country
- HOTH United States
- MGRX United States
- Employees
- HOTH N/A
- MGRX N/A
- Industry
- HOTH Biotechnology: Pharmaceutical Preparations
- MGRX Computer Software: Prepackaged Software
- Sector
- HOTH Health Care
- MGRX Technology
- Exchange
- HOTH Nasdaq
- MGRX Nasdaq
- Market Cap
- HOTH 15.6M
- MGRX 18.6M
- IPO Year
- HOTH 2019
- MGRX 2023
- Fundamental
- Price
- HOTH $1.29
- MGRX $1.73
- Analyst Decision
- HOTH Strong Buy
- MGRX
- Analyst Count
- HOTH 3
- MGRX 0
- Target Price
- HOTH $4.00
- MGRX N/A
- AVG Volume (30 Days)
- HOTH 230.9K
- MGRX 82.5K
- Earning Date
- HOTH 08-12-2025
- MGRX 08-14-2025
- Dividend Yield
- HOTH N/A
- MGRX N/A
- EPS Growth
- HOTH N/A
- MGRX N/A
- EPS
- HOTH N/A
- MGRX N/A
- Revenue
- HOTH N/A
- MGRX $516,030.00
- Revenue This Year
- HOTH N/A
- MGRX N/A
- Revenue Next Year
- HOTH N/A
- MGRX N/A
- P/E Ratio
- HOTH N/A
- MGRX N/A
- Revenue Growth
- HOTH N/A
- MGRX N/A
- 52 Week Low
- HOTH $0.65
- MGRX $1.32
- 52 Week High
- HOTH $3.80
- MGRX $7.66
- Technical
- Relative Strength Index (RSI)
- HOTH 50.80
- MGRX 53.47
- Support Level
- HOTH $1.22
- MGRX $1.42
- Resistance Level
- HOTH $1.31
- MGRX $1.76
- Average True Range (ATR)
- HOTH 0.08
- MGRX 0.14
- MACD
- HOTH -0.00
- MGRX -0.00
- Stochastic Oscillator
- HOTH 57.69
- MGRX 58.88
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).
About MGRX Mangoceuticals Inc.
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.